Your browser doesn't support javascript.
loading
The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis.
Kokkali, Stefania; Kotsantis, Ioannis; Magou, Elpida; Sophia, Talagani; Kormas, Theodoros; Diakoumis, Giakoumis; Spathas, Nikolaos; Psyrri, Amanda; Ardavanis, Alexandros.
Afiliação
  • Kokkali S; First Medical Oncology Clinic, Saint-Savvas Cancer Hospital, Athens, Greece. stefaniakokkali8@gmail.com.
  • Kotsantis I; Section of Medical Oncology, 2nd Department of Medicine and Laboratory, Faculty of Medicine, National and Kapodistrian University of Athens, Hippocratio General Hospital of Athens, Athens, Greece. stefaniakokkali8@gmail.com.
  • Magou E; Section of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, National and Kapodistrian Univeristy of Athens, Attikon University Hospital, Athens, Greece.
  • Sophia T; First Medical Oncology Clinic, Saint-Savvas Cancer Hospital, Athens, Greece.
  • Kormas T; First Medical Oncology Clinic, Saint-Savvas Cancer Hospital, Athens, Greece.
  • Diakoumis G; Department of Orthopedic Surgery, Saint-Savvas Cancer Hospital, Athens, Greece.
  • Spathas N; Department of Orthopedic Surgery, Saint-Savvas Cancer Hospital, Athens, Greece.
  • Psyrri A; Section of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, National and Kapodistrian Univeristy of Athens, Attikon University Hospital, Athens, Greece.
  • Ardavanis A; Section of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, National and Kapodistrian Univeristy of Athens, Attikon University Hospital, Athens, Greece.
Invest New Drugs ; 40(3): 668-675, 2022 06.
Article em En | MEDLINE | ID: mdl-35312944

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia